[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Subscription::
News& Events::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Indexing
                        
..
:: Volume 15, Issue 2 (Summer 2018) ::
Sci J Iran Blood Transfus Organ 2018, 15(2): 133-143 Back to browse issues page
The Significance of Ubiquitin-Proteasome Pathway in Glucocorticoid Resistance Development in Acute Lymphoblastic Leukemia
N. Dehghan Nayeri , P. Eshghi , K. Goudarzi pour , M. Darvishi , َ. Gharehbaghian
Abstract:   (4644 Views)
Abstract
Background and Objectives
ALL is the most common malignancy in childhood. Presently, approximately 20% of patients do not respond to treatment due to the resistance of leukemia blasts. Response to GCs is considered as the strongest independent factor in predicting ALL patients outcome. Therefore, identification of GCs resistance markers are the beneficial tools for improvement of prognostic strategies in ALL.
 
Materials and Methods
In this experimental study,  the protein-protein interaction network of fourteen significant down or up-regulated proteins in the proteome of human lymphoblastic cell treated with prednisolone and dexamethasone were analyzed by using the STRING online database.
 
Results
By using proteomics methods, fourteen down or up-regulated proteins, SRSF3, CNBP, VDAC1, SNX3, PFDN6, PSMB2, STMN1, PPP4R4, DUT, CAPZA1, CAPZB, PNP, CLIC1 and PSME1 were recognized in both the sensitive and resistant GC cell lines. Correlation between these proteins were analyzed by using the STRING database.
 
Conclusions 
Overall, the findings showed that the Ubiquitin-Proteasome pathway plays a pivotal role in inducing resistance to GC in ALL. Therefore, the study of key controlling proteins in this pathway can play an important role in clarifying the mechanisms of induction of resistance to GC and consequently the prognosis of the disease.
 
 
Keywords: Key words: Lymphoblastic Leukemia, Acute, Drug Resistance, Glucocorticoids, Biomarkers
Full-Text [PDF 1112 kb]   (2808 Downloads) |   |   Full-Text (HTML)  (7010 Views)  
Type of Study: Research | Subject: Hematology and Oncology
Published: 2018/06/15
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Dehghan Nayeri N, Eshghi P, Goudarzi pour K, Darvishi M, Gharehbaghian َ. The Significance of Ubiquitin-Proteasome Pathway in Glucocorticoid Resistance Development in Acute Lymphoblastic Leukemia. Sci J Iran Blood Transfus Organ 2018; 15 (2) :133-143
URL: http://bloodjournal.ir/article-1-1179-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 15, Issue 2 (Summer 2018) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.06 seconds with 39 queries by YEKTAWEB 4645